CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Clinical profile in chronic obstructive pulmonary disease patients and their evaluation with spirometry and 2d echo

Author: 
Dr. Vithal Narayan Dhadke, Dr. Mrs. Shubhangi Vithal Dhadke and Dr. Nikhil Raut
Subject Area: 
Health Sciences
Abstract: 

Introduction: Chronic obstructive pulmonary disease (COPD) is defined as a disease state characterized by airflow limitation that is not fully reversible. The Global Burden of Disease Study has projected that COPD, which ranked sixth as the cause of death in 1990, will become the third leading cause of death worldwide by 20202.The pooled global prevalence of COPD in adults 40 years or older is approximately 9 to 10% and is higher in smokers than non smokers, and is higher in men than in women. COPD includes emphysema, chronic bronchitis and small airway disease. Aims and Objectives: To study the clinical profile of Chronic Obstructive Pulmonary disease patients. Evaluation of COPD patients with spirometry and 2D Echocardiography. To correlate between spirometry and 2D Echocardiography findings. Evaluation of left ventricular function in COPD patients by 2D Echocardiography. Material s and Methods: The proposed study is comprised of 100 patients of COPD admitted in Dr. V. M. Govt. Medical College, Solapur. (Maharashtra) (India) They were studied clinically and with routine laboratory investigations, ECG, chest x ray, pulmonary function tests on spirometry and 2D and Doppler Echocardiography during their hospital stay. Inclusion criteria: Patients who present with symptoms suggestive of COPD like dyspnea, chronic cough with or without sputum production. Spirometry showing ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) expressed in percentage less than 70%. Exclusion criteria: Pulmonary tuberculosis, Pneumonia, Bronchiectasis. Pneumoconiosis. Primary cardiovascular or renal disease particularly if these result in pulmonary edema. Patients with rheumatic valvular heart disease, Ischemic heart disease and hypertension. Patients with Bronchial Asthma. Results: All patients in our study were more than 40 years of age indicating a rising trend of COPD in patients above the age of 40 years. The mean age was 62 ± 9 years. In our study COPD was predominantly found in males, comprising 80% of the total patients and Male: Female= 4:1. 75% of the patients in our study were smokers indicating higher incidence of COPD in smokers than non smokers. The common symptoms were dyspnea and cough with expectoration. Most common sign was wheeze present in 70% of COPD patients in our study. Conclusions: 1) 25% of the patients had normal chest x-ray. Changes observed in chest x-ray were prominent bronchovascular markings, changes of emphysema, prominent central pulmonary artery and cardiomegaly. 2) 50% of the patients had normal ECG. Most common ECG finding in our study was P pulmonale present in 40% of the patients. 3) Spirometry is an essential tool to establish the diagnosis and grading of severity of COPD by calculating FEV1 % predicted and FEV1/ FVC.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran